Form 4 for ENTA ENANTA PHARMACEUTICALS INC
Accepted 2025-12-03 00:00:00 ET · period of report 2025-12-01 · accession 0002064832-25-000042 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-03 | 2025-12-01 | ENTA | Luly Jay R. | Pres, CEO, Dir | F - Tax | $14.12 | -1,885 | 862.8K | -0.2% | -$26.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-01 | F | D | 1,885 | $14.12 | 862,769 | D | — | — | (F1) Represents the number of shares of ENTA common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit award granted on November 19, 2021. |